US EditionPublished • loading... • Updated
Autolus Therapeutics’ (AUTL) “Outperform” Rating Reiterated at William Blair
Summary by reporter.am
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Autolus Therapeutics’ (AUTL) “Outperform” Rating Reiterated at William Blair
William Blair restated their outperform rating on shares of Autolus Therapeutics (NASDAQ:AUTL – Free Report) in a research report sent to investors on Wednesday,RTT News reports. Other equities analysts have also recently issued reports about the stock. Wells Fargo & Company decreased their target price on shares of Autolus Therapeutics from $6.00 to $5.00 and […]
·Maryland, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
